Ad26.cov2-s/elasomeranLack of efficacy:2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1942卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32626-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[21] Ad26.COV2-S/AZD-1222Thyrotoxicosis: 7 case reports
Reactions Weekly, 2022, 1897 (1) : 19 - 19
[22] Ad26.cov2-s/elasomeran/tozinameranThrombotic thrombocytopenic purpura: 37 case reports
Reactions Weekly, 2022, 1914 (1) : 20 - 20
[23] Ad26.cov2-s/elasomeranDRESS syndrome: case report
Reactions Weekly, 2022, 1927 (1) : 20 - 20
[24] Ad26.cov2-s/AZD-1222/metforminType 1 diabetes mellitus and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1930 (1) : 16 - 16
[25] Ad26.CoV2-S/heparinVarious toxicities: case report
Reactions Weekly, 2021, 1882 (1) : 23 - 23
[26] Ad26.COV2-S/AZD-1222Thrombotic thrombocytopenia: 5 case reports
Reactions Weekly, 2022, 1889 (1) : 18 - 18
[27] Ad26.cov2-s/azd-1222Thrombosis and thrombocytopenia: 6 case reports
Reactions Weekly, 2023, 1946 (1) : 15 - 15
[28] Ad26.COV2-S/AZD-1222/elasomeranTransverse myelitis: 3 case reports
Reactions Weekly, 2023, 1957 (1) : 16 - 16
[29] Ad26.cov2-s/azd-1222/tozinameranAcute uveitis: 11 case reports
Reactions Weekly, 2023, 1945 (1) : 20 - 20
[30] Ad26.cov2-s/azd-1222/tozinameranMyopericarditis and pericarditis: 3 case reports
Reactions Weekly, 2023, 1973 (1) : 18 - 18

← 1 2 3 4 5 →